Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / @xirurgi_2025 / @xirurgi_2025 - 393 - файл

.pdf
Скачиваний:
0
Добавлен:
29.08.2026
Размер:
45 Мб
Скачать
62 Lymphoedema and ChroniC SweLLing
https://t.me/medicina_free
The Stemmer Sign
A positive Stemmer sign (swelling, inammation and adipose depo­sition thickening the skin, making it more dicult to lift and pinch the skin on the dorsum of the hand or foot; Figure2.3) makes lym­phoedema likely, although a negative sign does not rule out early­stage lymphoedema (Greene and Goss2018, p.14).
The Stemmer sign is used as part of a physical examination to support the diagnosis of established lymphoedema. If the examiner cannot pinch the skin of the dorsum of the foot or hand, then this positive nding is associated with lymphoedema. Checking for a pos­itive or negative sign as part of the physical examination allows the clinician to correlate what is presented and seen and felt alongside taking the patient’s history of the onset. It is a simple check to iden­tify that the swelling is rm and established.
FIGURE 2.3 Stemmer sign.
Source: Reproduced by permission from Kamijo etal.2021.
Lymphoedema and Chronic Swelling 63
https://t.me/medicina_free
TABLE 2.10 
Examination of tissues and skin Signs of lymphoedema
Texture Tissue is soft and pitting
Skin changes Skin folds, from creases in the skin predominantly
Temperature Whether the limb is warmer or cooler than normal Sensation Consider lack of sensation or reduced sensation Colour Darkened skin tone or staining located to one area or
Physical examination ofthe skin andtissues.
Feels less elastic and rm Changes in consistency of the tissue or compare to a
unilateral limb for comparison
Thickened coarse skin with positive Stemmer sign
noted in the toes and around or above the ankle area
Hyperkeratosis, thickening of the outer layer of the
skin, which contains a tough, protective protein called keratin
Lymphangiectasia, a pathological dilation of
lymph vessels
Papillomatosis, characterised by the appearance of
numerous papules
Peau d’orange (French for ‘orange peel skin’ or, more
literally, ‘skin of an orange’), describing hair follicles getting buried in the oedema resembling orange peel
bilateral can be venous congestion and will vary dependent on skin tone
The physical examination of the texture of the skin and subcutane-
ous tissues should note skin changes within the assessment (Table2.10).
Simple Steps inPhysical Examination
Look– for asymmetries, skin conditions, congestion. Pay particu-
lar attention to skin changes (peau d’orange, papilloma, brosis).
Touch and feel– palpation, pitting, check Stemmer sign, rmness.Ask questions – subjective assessment can provide essential
information to form the diagnosis and future treatment plan.
64 Lymphoedema and ChroniC SweLLing
https://t.me/medicina_free
TABLE 2.11 
Stage 0 Clinically normal limb with abnormal lymphatic transport
Stage 1 Early oedema responsive to limb elevation Stage 2 Firmer tissue with fewer signs of pitting oedema
Stage 3 Fibroadipose deposition and skin changes
Source: Adapted from International Society of Lymphology (2013) and Greene and Goss (2018), p.12.
Stages oflymphoedema.
that is apparent only with lymphoscintigraphy
unresponsive to elevation
Step4: Staging andSeverity
The pathophysiology and staging of lymphoedema are the same whether the problem is primary or secondary (Greene and Goss2018, p.12) (Table2.11).
In the initial stages of swelling, mild or uctuating pitting oedema may be noted. Pitting oedema occurs when excess uid in the body causes swelling that indents when pressure is applied, for example with a nger pressing down, or marks that can be noted as indents from socks. This early swelling usually resolves with elevation. As symptoms progress from Stage 1 to Stage 2, the subsidence of swelling of the aected limb becomes more and more resistant to elevation or overnight rest. This indicates that the lymphatic system is increasingly unable to maintain uid balance by collecting and transporting uid from the interstitial spaces to the circula­tion and has become congested (British Lymphology Society 2020). If symptoms progress further or are left untreated, unevenly distributed brosis and adipose tissue replace the interstitial uid. Pitting oedema then becomes dicult or impossible to treat and, as a result, subcutaneous tissues become thickened and rm, with the development of deep folds and the emergence of skin changes (British Lymphology Society2020).
According to the International Society of Lymphology (2013), the severity of oedema is classied as:
Mild (<20% increase in limb volume)Moderate (20–40%)Severe (>40%)
Step5: Measurements
Limb volume measurement is a method of measuring that provides a
Lymphoedema and Chronic Swelling 65
https://t.me/medicina_free
swelling; it can be conducted with a tape measure, perometer or water displacement. For the most part and within community set­tings, limb volume measurement may not be attainable, thus simple measurements at key circumference points are recommended. It is noted that tape measures can beunreliable for accurate monitoring (particularly in children) because of the diculty of measuring the same position over time and holding the tape with the same tightness (Houwen etal.2022; Greene and Goss2018, p.12).
Step6: Psychosocial Impact
The assessment must consider the negative psychosocial impact on those aected. People with lymphoedema have statistically signi­cantly poorer social well- being, including self- perceptions of body image and appearance, and diminished sexual and social functioning. They may experience negative self- identity, emotional disturbance and psychological distress, and may feel socially isolated or marginalised, as if they are a nancial burden and unsupported at work (Fu etal.2013) (Table2.12). Key factors that impair the quality of life in people with lymphoedema include the frequency of acute inammatory episodes, the presence of pain, skin quality and reduced limb mobility, alongside nancial concerns (Bowman etal.2020; Morgan etal.2005).
TABLE 2.12 
Impact Contributing factors
Body image disturbance Feeling that aected limbs are ugly,
Grief Loss of the person’s pre­Frustration, anxiety Lack of nancial support
Fear Afraid that lymphoedema will get worse Guilt Feeling that the person did something
Sadness Having to wear unfashionable or unsexy clothes
Depression Need for daily management of symptoms
Source: Adapted from Fu etal. (2013).
Psychosocial impacts oflymphoedema.
unattractive, disgusting
lymphoedema being
Burden of daily lymphoedema management Lack of importance accorded to lymphoedema
by health services
themselves to cause the lymphoedema
to t the swollen limb
Impairment of physical function
66 Lymphoedema and ChroniC SweLLing
https://t.me/medicina_free
People with lymphoedema therefore require health professionals to initiate a conversation to identify how the disease is aecting them psychosocially, and to discuss ways to manage the impact, setting realistic expectations for what can be done and the kind of support that might be available. The quality- of- life measure for limb lym­phoedema (LYMQOL) (Keeley et al. 2010) is a practical tool for assessing the impact of symptoms on the patient, to help inform clin­ical decisions and to measure the results of progress in treatment.
MANAGEMENT CHALLENGES
Eective and appropriate management of lymphoedema requires a system- wide approach to minimise variations in outcomes and quality of care and to reduce costs. Untreated and poorly managed lymphoe­dema not only severely impairs patients’ quality of life and increases their long- term health risks; it also has a high cost for health services and in some cases can triple the cost of treatment (Healthy London Partnership2020). Late diagnosis can be reective of inecient sys­tems and processes, which in turn can result in a convoluted patient journey leading to a negative impact from social and economic perspec­tives. Sub- therapeutic management for leaking legs alongside unneces­sary recurrent cellulitis infections should be challenged and considered as patient harm (Atkin etal.2021). Providing sub- therapeutic manage­ment, largely related to the sub- optimal dosage of compression, is not an ecient method for optimising nursing time (Table2.13).
Good management includes accurate and timely diagnosis. Early recognition and prompt and eective treatment enable symptoms to be controlled and prevent escalation (Health Service Executive (Ireland)2019, p.33). Monitoring for signs of lymphoedema is par­ticularly important in patients with cancer, vascular conditions or current wounds, those who use a wheelchair and the elderly (Health Service Executive (Ireland)2019, p.33).
Delayed or absent diagnosis can lead to inappropriate treatment, late referral to appropriate health services, the development of com­plications and co- morbidities, and exacerbations of the impact on the person’s quality of life. It may also cause additional physical symp­toms such as diculty in moving the aected area, general discomfort and heaviness from unmanaged swelling, recurrent skin infections
Lymphoedema and Chronic Swelling 67
https://t.me/medicina_free
TABLE 2.13 How can thecomplexities beaddressed fora better system–
what can Ido asa clinician?
Risks to patient
and system
Sub- therapeutic
management of ‘leaking legs’
Recurrent
cellulitis
Convoluted
patient journey
Negative social
and economic impact
Risk reduction focus Considerations and
interdependencies
Prompt assessment and
therapeutic management to reduce the risk of avoidable harm and infection
Recognition of cellulitis as
an early warning sign that swelling is evident
Prompt assessment and
advice on skincare and optimising oedema management to reduce the potential recurrence of cellulitis and sepsis risk and reduce harm­reducing risk factors through self-
Ensuring eective
therapeutic compression garments to reduce recurrent infections
Ensuring a smooth pathway
that reects earlier recognition, identication, intervention and management across the pathway
Identifying where there is a
multifactorial biopsychosocial negative impact on patients and the wider healthcare system and workforce
management
Lack of therapeutic
management could be considered an avoidable harm
Provision of patient
education to optimise self- management
Raising public
awareness of lower limb conditions so patients recognise when to seek help.
Improve healthcare
professionals’ knowledge and skills in recognition and signposting to appropriate services.
Local pathways that are
collaborative and seamless across primary care, community, specialist and acute services
Reviewing local
systems to identify gaps in provision and the negative impact on the population and workforce
(Continued)
68 Lymphoedema and ChroniC SweLLing
https://t.me/medicina_free
TABLE2.13 (Continued)
Optimising
systems, processes and resources
Identifying system pathways
to ensure long­support is available for patients to enable
long self-
life­management, e.g. hosiery, reassessment and review if changes in condition
Identifying pathways to
support self­e.g. access to therapeutic compression garments in a timely manner, and patient- initiated follow-
term
management,
up
and a change in the texture of the skin. Watery lymphorrhoea (lymph uid) leaking from the skin and unmanaged swelling can cause a breach of skin integrity and increase the risk of infection. These com­plications can lead to patients experiencing psychosocial problems such as forced absence from work, isolation, absence from social activities, anxiety and depression, increasing the need for health ser­vice intervention and demand on NHS resources and economic costs.
Multidisciplinary
collaboration ensures improvements are made where harm is occurring.
Consideration for data
collection, e.g. audits to identify areas of good practice or concerns
Leadership to inuence
and shape future systems to address health inequalities and continuous improvement
LYMPHOVENOUS DISEASE
It is important to be alert for a number of changes in the appearance of the skin, veins and underlying tissue that indicate the presence oflymphovenous disease, a progression of lymphoedema with venous involvement. The presence of DVT and red legs indicates unmanaged or poorly managed lymphovenous disease. The most common pres­entation of DVT in patients with advanced cancer is asymmetrical bilateral leg oedema, but it is not limited to this group; DVT is a risk factor for those with venous disease. Progression of venous disease makes the patient’s condition and treatment more complex. It is therefore important to understand the factors involved and the role of
Lymphoedema and Chronic Swelling 69
https://t.me/medicina_free
cellulitis, lymphorrhoea, inamed or red legs and DVT so that they can be recognised, diagnosed and managed appropriately.
Cellulitis is frequently misdiagnosed (Patel etal.2019). The signs of cellulitis are similar to those of inamed or red legs and congestion (see later Table2.15). However, vigilance for cellulitis is important, as it will also complicate and exacerbate lymphoedema and make treat­ment more dicult (see Chapter5 for the signs of venous disease).
Lymphorrhoea
Lymphorrhoea indicates unmanaged, uncontrolled lymphoedema, and carries severe risks to the patient’s health and quality of life (British Lymphology Society2023) and utilises signicant healthcare resources. Lymphorrhoea occurs because the pressure inside the tissues has become too great to contain the oedema. As a result, the lymphatic uid leaks from the skin. This causes skin maceration and increases the risk of cellulitis. The most common place for lymphor­rhoea to occur is the legs, but it can aect any area of the body.
Common triggers for lymphorrhoea are:
Immobility and dependency.Non- adherence to therapeutic management.Health changes, such as the development of breathing dicul-
ties or cellulitis.
Low albumin protein level.Oedema at the end of life (i.e. ‘leaky legs’).Lack of recognition and ineective management by healthcare
practitioners.
Lymphorrhoea may also be a secondary symptom of cellulitis, triggered by the inammatory response to cellulitis. Prompt manage­ment is essential to avoid the cascade of harms that may result from uncontrolled ‘leaky legs’. There is a need rst to establish the under­lying cause of the lymphorrhoea, to inform the optimal management approach. Lymphorrhoea usually responds well and rapidly to an appropriate therapeutic intervention including skin care and com­pression. Once controlled, the risk of cellulitis is reduced and the patient can regain a better quality of life (Patel etal. 2019; British Lymphology Society2023). There are signs that can increase the risk of lymphorrhoea for the more vulnerable groups (Table2.14).
70 Lymphoedema and ChroniC SweLLing
https://t.me/medicina_free
TABLE 2.14 
oflymphorrhoea.
Recent exacerbation of poor health Recent and sudden reduction in mobility Taut, shiny skin Inammatory skin conditions Previous lymphorrhoea
optimal management
Sub­Lymph blisters on the skin Palliative General systemic overload
Source: Adapted from British Lymphology Society (2023).
Signs that thepatient might beat increased risk
Red or Inflamed Legs
‘Red legs’ is the predominant term used to describe congestion and inammation in the lower legs; it is a condition commonly seen in patients with chronic venous disease and chronic oedema, or lower limb dermatological conditions (Elwell2020) and has been an important tool to dierentiate between cellulitis and the inammatory processes pre­sent. An episode of acute lipodermatoschlerosis is often misdiagnosed as cellulitis. Studies have shown that around 28–33% of patients treated for cellulitis are misdiagnosed, which subsequently leads to avoidable and costly hospitalisation and potentially hazardous use of intravenous anti­biotics that may compound the evolution of antibiotic- resistant bacteria (Edwards etal.2020). Legs need to be assessed with care, as conditions related to them may have several causes that require dierent treat­ments. The British Lymphology Society’s Red Legs Pathway is a useful guide to assessment and management (Elwell2020) and is a tool to dif­ferentiate between cellulitis and the inammatory causes of ‘red legs’.
It is important to note that the term ‘red legs’ is not always a use­ful term for darker skin tones; the expectation of redness can cause the condition to be missed. At the time of writing there is no national consensus on a new descriptor. It is recognized that there is a need to establish skills in assessing signs and symptoms in people with darker skin tones within the health care sector more broadly and lower limb management specically (Wounds UK, 2021).
When examining the limb the aim is to recognise inammation. In lighter skin tones the inammation can be perceived as red or a livid dark
Lymphoedema and Chronic Swelling 71
https://t.me/medicina_free
brown due to the higher contrast. In darker skin tones, the colour change can be more subtle but also with a red or even purple hue or simply a darkening of their skin tone. Thus comparison to the other limb or another body part is critical as is asking the patient for their impression of the skin changes. Feeling for warmth or changes in texture is important.
Red legs may present either bilaterally or unilaterally. There are many possible dierential diagnoses for each. Bilateral redness with wet and leaky legs indicates lymphorrhoea. If redness is unilateral, and the patient is also unwell with fever, raised temperature, pain and related symptoms, cellulitis should be considered. Cellulitis is rarely a cause of problems when redness is bilateral (British Lymphology Society and Lymphoedema Support Network 2016). For dierential diagnosis see Table2.15. For treatment of red legs see Table2.16.
Treatment for red legs begins with daily washing with a soap substitute in warm water, followed by careful but thorough drying of the skin (patting dry) and the application of an emollient. A focus on appropriate compression therapy to address the unmanaged swelling is essential. In the event of mild swelling with no associated risk
TABLE 2.15 Dierential diagnosis ofred legs.
Bilateral red legs– in a well patient
Lipodermatosclerosis Varicose eczema Gravitational dermatitis Contact dermatitis Fungal infection/Intertrigo in
skin folds
Drug-
induced
induced redness, e.g. sunburn
Heat-
and radiators/open res/hot water bottles
Underlying medical condition–
consider diagnosis of heart failure
Source: Adapted from Elwell (2020).
Unilateral red legs– what to consider
Assess deep vein thrombosis (DVT)
risk and rule out if suspected via local policy
Consider venous
hypertension– varicosities Acute lipodermatosclerosis Phlebitis Staining red ags: In unilateral leg
consider extrinsic venous
compression due to undiagnosed
tumour/recurrent disease– exclude
with appropriate pelvic
investigation/blood tests DVT– exclude with venous duplex
and D-
dimer
Соседние файлы в папке @xirurgi_2025